Search the Newsreel

Guardant Health hits 52-week high after guidance hike

[Rolled newspaper with the headline Quarterly Results] Zerbor Guardant Health (GH [https://seekingalpha.com/symbol/GH]) added nearly 10% at the market open on Friday to hit a new 52-week high after the blood-based cancer test maker reported Q2 2026 revenue well surpassing the consensus and raised its …

Ardagh Metal Packaging S.A. (AMBP) Q2 2024 Earnings Report - Results, Call & Slides

Ardagh Metal Packaging S.A. (AMBP) reported its Q2 2024 earnings, beating analyst EPS estimates with an actual EPS of $0.06 against a consensus of $0.05. However, the company missed revenue expectations, posting $1.26 billion compared to an expected $1.32 billion. The report also includes …

Is Guardant Health Inc (GH) Overvalued After Q2 Earnings Miss? E

Guardant Health Inc (GH) reported a strong Q2 2026 revenue growth of 44% to $335.0 million, driven by oncology and a surging screening division, but net losses widened to $120.1 million due to increased operational expenses. Despite raising 2026 revenue guidance, GuruFocus deems the …

Guardant Health stock rises after guidance hike (GH:NASDAQ)

Guardant Health (GH) stock rose nearly 10% and hit a new 52-week high after reporting Q2 2026 revenue that significantly beat consensus estimates. The blood-based cancer test maker also raised its full-year outlook, with its oncology portfolio growing 38% year-over-year and screening revenue seeing …

Guardant Health Inc (GH) (Q2 2026) Earnings Call Highlights: Revenue Surges 44% on FDA Approval ...

Guardant Health, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Achieved …

Guardant Health, Inc. Stock 12‑Month Price Target Raised to $180.91, Implies 19% Upside

Guardant Health, Inc.'s stock's 12-month average price target has been raised from $174.61 to $180.91, based on estimates from 23 analysts, implying a 19% potential upside from the Jul. 30 closing price. The consensus rating remains "Buy" among 29 covering analysts, with the majority …

Sharda Cropchem Ltd (BOM:538666) (Q1 2027) Earnings Call Highlights: Revenue Climbs 9% as ...

Guardant Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:GH) 2026-07-31

Garda Property Group (ASX:GDF) Shares Reflect Profit Recovery And Debt Unease

Does Guardant’s Surging Revenue and Deeper Losses Reframe the Growth Thesis for GH?

Guardant Health reported past second-quarter 2026 results showing sales of US$334.98 million versus US$232.09 million a year earlier, alongside a wider net loss of US$120.14 million and loss per share of US$0.90. While revenue expanded sharply over both the quarter and first half of …

How Investors Are Reacting To Guardant Health (GH) Spotlighting Shield Test And Teeing Up Earnings

Guardant Health is gaining investor attention following a colorectal cancer screening awareness campaign featuring Patrick Dempsey for its FDA-approved Shield blood test and ahead of its upcoming quarterly earnings report. The Shield test is the only FDA-approved blood test included in major colorectal cancer …

Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Guardant Health (GH) reported revenue of $334.98 million, up 44.3% over the same period last year. EPS came in at -$0.42, compared to -$0.44 in the year-ago quarter. The reported revenue represents a surprise of +6.01% over the …

Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

Second quarter 2026 revenue growth of 44% driven by strong performance in Oncology and Screening Raises 2026 revenue guidance to $1.34 to $1.36 billion, representing growth of 36% to 38% PALO ALTO, Calif., July 30, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision …

Guardant Health: Q2 Earnings Snapshot

Guardant Health Inc. (GH) reported a Q2 loss of $120.1 million, or 90 cents per share, which adjusted to 42 cents per share. This loss exceeded Wall Street's expectation of 40 cents per share. However, the oncology testing services provider surpassed revenue forecasts, posting …

Guardant Health earnings on deck after catalyst-rich quarter

Guardant Health (GH) is set to release its Q2 earnings, with analysts anticipating a loss of 76 cents per share on revenues of $314.3 million. The company has experienced significant stock growth recently due to the American Cancer Society endorsing its Shield blood test, …

Guardant Health, Stock Of The Day, Offers Entry With Earnings Due

Guardant Health is the IBD Stock Of The Day in a thriving market for colon cancer screening tests. Health and biotech stocks are acting well in the current market. Several biotech and health names can be found on the IBD 50 list of top …

Kardan Real Estate Enterprise & Development Ltd. Revenue Breakdown – TASE:KARE

Guardant Health Inc (GH) pullback contrasts with active weekly trend

The healthcare diagnostics stock weakened over the latest week, but the longer 12-week performance and trend screen leave the setup mixed.

Ardagh Metal Packaging S.A. (NYSE:AMBP) Receives Average Recommendation of "Hold" from Brokerages

Ardagh Metal Packaging S.A. (AMBP) has received a consensus "Hold" rating from brokerages, with five analysts recommending "Hold" and one recommending "Buy," and an average 12-month price target of $4.86. The company recently reported strong quarterly earnings of $0.11 per share, beating estimates, and …

Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates

Guardant Health (GH) reported a Q2 loss of $0.42 per share, which was worse than the Zacks Consensus Estimate of a $0.40 loss, but its revenues of $334.98 million surpassed estimates by 6.01%. Despite outperforming the market year-to-date, the stock currently holds a Zacks …

Renaissance Technologies LLC Has $21.05 Million Position in StandardAero, Inc. $SARO

Renaissance Technologies LLC significantly increased its stake in StandardAero, Inc. (NYSE:SARO) by 36.1% in the first quarter, now holding 814,800 shares valued at $21.05 million. This increase comes as StandardAero reported a strong quarterly earnings beat and provided optimistic guidance for fiscal year 2026. …

Guardant Health Inc (GH) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Guardant Health Inc (GH), detailing its volatility, financial metrics, and investment risk. The company has a beta of 1.60, indicating higher volatility compared to the S&P 500, and is ranked 72nd out of 199 in the Healthcare …

Guardant Health (NASDAQ:GH) Delivers Strong Q2 CY2026 Numbers, Stock Soars

Guardant Health (NASDAQ:GH) Delivers Strong Q2 CY2026 Numbers, Stock Soars Diagnostics company Guardant Health (NASDAQ:GH) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 44.3% year on year to $335 million. The company's full-year revenue guidance of $1.35 billion at …

StandardAero, Inc. (SARO) Reports Next Week: Wall Street Expects Earnings Growth

StandardAero, Inc. (SARO) is projected to report increased earnings and revenue for the quarter ended June 2026, with Wall Street expecting a 75% year-over-year EPS growth. The company's Zacks Earnings ESP is currently negative at -1.45%, suggesting analysts have recently turned more bearish, making …

StandardAero, Inc. (SARO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of StandardAero, Inc. (SARO), highlighting its current valuation score of 8.10 within the Aerospace & Defense industry. It details the company's current P/E ratio and notes that relevant data for P/B, P/S, and P/CF have not yet been …

StandardAero, Inc. (SARO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of StandardAero, Inc. (SARO), including its current stock price, support and resistance levels, and performance based on various technical indicators and moving averages. While the stock is suitable for range-bound swing trading, the overall signal from technical indicators …

Two Guardant Health investor chats are set for Aug. 12 and Sept. 15

Guardant Health, a precision oncology company, announced its participation in two upcoming investor conferences: the Canaccord Genuity 46th Annual Growth Conference on August 12th in Boston, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15th in New York. The company will …

Guardant Health to Participate in Upcoming Investor Conferences

PALO ALTO, Calif., July 29, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Canaccord Genuity 46th Annual Growth Conference in Boston, MA Fireside chat on Wednesday, August 12th at …

Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer

Guardant Health has launched an emotional tribute video featuring actor Patrick Dempsey to honor those who have died from colorectal cancer, a disease that claims over 55,000 American lives annually. The video underscores the critical need for screening, particularly with Guardant Health's innovative Shield™ …

Guardant Health Inc (GH) Institutional Confidence

Guardant Health Inc (GH) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 101.63%, a 4.26% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 504.12K shares, representing 0.53% of …

StandardAero, Inc. $SARO Holdings Raised by Gabelli Funds LLC

Gabelli Funds LLC significantly increased its stake in StandardAero, Inc. (NYSE:SARO) by 1,202.2% in the first quarter, now holding 182,311 shares valued at $4.7 million. This move is part of broader institutional interest, with other major investors like Goldman Sachs and UBS Asset Management …

Price to earnings forward of Ardagh Metal Packaging S.A. – OTC:AMPWF

This article provides financial information for Ardagh Metal Packaging S.A. (OTC:AMPWF), specifically highlighting its forward price-to-earnings ratio. It emphasizes that the data is "Made by humans" and sourced from ICE Data Services and FactSet Research Systems Inc. The content is primarily a data point …

Guardant Health (GH) Q2 Earnings Report Preview: What To Look For

Enterprise value to EBIT forward of Ardagh Metal Packaging S.A. – OTC:AMPWF

This article focuses on the "Enterprise value to EBIT forward" metric for Ardagh Metal Packaging S.A. (OTC:AMPWF). It mentions the company's stock information and indicates that no trades have occurred, with the market currently closed. The content is primarily a financial data page from …

Earnings Estimates Rising for Ardagh Metal Packaging (AMBP): Will It Gain?

Investors might want to bet on Ardagh Metal Packaging S.A. (AMBP), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. The …

Are You Looking for a Top Momentum Pick? Why Ardagh Metal Packaging S.A. (AMBP) is a Great Choice

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …